These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36913629)

  • 1. RISK FACTORS FOR SURGERY OR BLINDNESS IN NEOVASCULAR GLAUCOMA EYES TREATED WITH ANTI-VEGF INJECTIONS BY A RETINA SPECIALIST.
    Massenzio E; Xu D; Abishek R; Wibbelsman TD; Sheng Y; Obeid A; Bhatt S; Zhang Q; Sharpe J; Park CH; Spirn MJ; Gupta OP; Chiang A; Shukla A; Shalaby WS; Myers JS; Hsu J
    Retina; 2023 Jul; 43(7):1150-1159. PubMed ID: 36913629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Panretinal photocoagulation with simultaneous cryoretinopexy or intravitreal bevacizumab for neovascular glaucoma.
    Tatsumi T; Yamamoto S; Uehara J; Sugawara T; Baba T; Inoue M; Hata H; Mitamura Y
    Graefes Arch Clin Exp Ophthalmol; 2013 May; 251(5):1355-60. PubMed ID: 23250484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab.
    Olmos LC; Sayed MS; Moraczewski AL; Gedde SJ; Rosenfeld PJ; Shi W; Feuer WJ; Lee RK
    Eye (Lond); 2016 Mar; 30(3):463-72. PubMed ID: 26681145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-vascular endothelial growth factor for neovascular glaucoma.
    Simha A; Aziz K; Braganza A; Abraham L; Samuel P; Lindsley KB
    Cochrane Database Syst Rev; 2020 Feb; 2(2):CD007920. PubMed ID: 32027392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of treatment of neovascular glaucoma with intravitreal bevacizumab.
    Moraczewski AL; Lee RK; Palmberg PF; Rosenfeld PJ; Feuer WJ
    Br J Ophthalmol; 2009 May; 93(5):589-93. PubMed ID: 19074917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.
    Wakabayashi T; Oshima Y; Sakaguchi H; Ikuno Y; Miki A; Gomi F; Otori Y; Kamei M; Kusaka S; Tano Y
    Ophthalmology; 2008 Sep; 115(9):1571-80, 1580.e1-3. PubMed ID: 18440643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal bevacizumab for neovascular glaucoma in uveal melanoma treated by proton beam therapy.
    Mahdjoubi A; Najean M; Lemaitre S; Dureau S; Dendale R; Levy C; Rouic LL; Desjardins L; Cassoux N
    Graefes Arch Clin Exp Ophthalmol; 2018 Feb; 256(2):411-420. PubMed ID: 29116399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of neovascular glaucoma in eyes presenting with moderate to good visual potential.
    Rani PK; Sen P; Sahoo NK; Senthil S; Chakurkar R; Anup M; Behera UC; Sivaprasad S; Das T;
    Int Ophthalmol; 2021 Jul; 41(7):2359-2368. PubMed ID: 33745037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal bevacizumab combined with panretinal photocoagulation in the treatment of open angle neovascular glaucoma.
    Ciftci S; Sakalar YB; Unlu K; Keklikci U; Caca I; Dogan E
    Eur J Ophthalmol; 2009; 19(6):1028-33. PubMed ID: 19882572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of neovascular glaucoma with panretinal photocoagulation, intravitreal bevacizumab, and subsequent trabeculectomy with mitomycin C.
    Alkawas AA; Shahien EA; Hussein AM
    J Glaucoma; 2010 Dec; 19(9):622-6. PubMed ID: 20179624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination intravitreal bevacizumab/panretinal photocoagulation versus panretinal photocoagulation alone in the treatment of neovascular glaucoma.
    Ehlers JP; Spirn MJ; Lam A; Sivalingam A; Samuel MA; Tasman W
    Retina; 2008 May; 28(5):696-702. PubMed ID: 18463512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal bevacizumab and aqueous shunting surgery for neovascular glaucoma: safety and efficacy.
    Eid TM; Radwan A; el-Manawy W; el-Hawary I
    Can J Ophthalmol; 2009 Aug; 44(4):451-6. PubMed ID: 19606170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visual Outcomes in Eyes With Neovascular Glaucoma and Anterior Segment Neovascularization Without Glaucoma.
    Sastry A; Ryu C; Jiang X; Ameri H
    Am J Ophthalmol; 2022 Apr; 236():1-11. PubMed ID: 34562418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-VEGF treatment is the key strategy for neovascular glaucoma management in the short term.
    Sun Y; Liang Y; Zhou P; Wu H; Hou X; Ren Z; Li X; Zhao M
    BMC Ophthalmol; 2016 Aug; 16(1):150. PubMed ID: 27576739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of intravitreal bevacizumab in eyes with neovascular glaucoma undergoing Ahmed glaucoma valve implantation: 2-year follow-up.
    Arcieri ES; Paula JS; Jorge R; Barella KA; Arcieri RS; Secches DJ; Costa VP
    Acta Ophthalmol; 2015 Feb; 93(1):e1-6. PubMed ID: 24989855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenesis in glaucoma filtration surgery and neovascular glaucoma: A review.
    Kim M; Lee C; Payne R; Yue BY; Chang JH; Ying H
    Surv Ophthalmol; 2015; 60(6):524-35. PubMed ID: 25980779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-vascular endothelial growth factor for neovascular glaucoma.
    Simha A; Braganza A; Abraham L; Samuel P; Lindsley K
    Cochrane Database Syst Rev; 2013 Oct; 10(10):CD007920. PubMed ID: 24089293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal bevacizumab as an adjunct treatment for neovascular glaucoma.
    Hasanreisoglu M; Weinberger D; Mimouni K; Luski M; Bourla D; Kramer M; Robinson A; Axer-Siegel R
    Eur J Ophthalmol; 2009; 19(4):607-12. PubMed ID: 19551676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bevacizumab in conjunction with panretinal photocoagulation for neovascular glaucoma.
    Wasik A; Song HF; Grimes A; Engelke C; Thomas A
    Optometry; 2009 May; 80(5):243-8. PubMed ID: 19410229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intravitreal bevacizumab on iris vessels in neovascular glaucoma patients.
    Sugimoto Y; Mochizuki H; Okumichi H; Takumida M; Takamatsu M; Kawamata S; Kiuchi Y
    Graefes Arch Clin Exp Ophthalmol; 2010 Nov; 248(11):1601-9. PubMed ID: 20524132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.